Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Intratumoral Tcf1+PD-1+CD8+ T Cells with Stem-like Properties Promote Tumor Control in Response to Vaccination and Checkpoint Blockade Immunotherapy
Imran Siddiqui, Karin Schaeuble, Vijaykumar Chennupati, et al.
Immunity (2019) Vol. 50, Iss. 1, pp. 195-211.e10
Open Access | Times Cited: 1239

Showing 1-25 of 1239 citing articles:

Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance
Sreya Bagchi, Robert Yuan, Edgar G. Engleman
Annual Review of Pathology Mechanisms of Disease (2020) Vol. 16, Iss. 1, pp. 223-249
Open Access | Times Cited: 1564
Defining ‘T cell exhaustion’
Christian U. Blank, W. Nicholas Haining, Werner Held, et al.
Nature reviews. Immunology (2019) Vol. 19, Iss. 11, pp. 665-674
Open Access | Times Cited: 1178
Clonal replacement of tumor-specific T cells following PD-1 blockade
Kathryn E. Yost, Ansuman T. Satpathy, Daniel K. Wells, et al.
Nature Medicine (2019) Vol. 25, Iss. 8, pp. 1251-1259
Open Access | Times Cited: 1166
CD8+ T cell states in human cancer: insights from single-cell analysis
Anne M. van der Leun, Daniela S. Thommen, Ton N. Schumacher
Nature reviews. Cancer (2020) Vol. 20, Iss. 4, pp. 218-232
Open Access | Times Cited: 1116
Pan-cancer single-cell landscape of tumor-infiltrating T cells
Liangtao Zheng, Shishang Qin, Wen Si, et al.
Science (2021) Vol. 374, Iss. 6574
Closed Access | Times Cited: 829
Neoadjuvant checkpoint blockade for cancer immunotherapy
Suzanne L. Topalian, Janis M. Taube, Drew M. Pardoll
Science (2020) Vol. 367, Iss. 6477
Open Access | Times Cited: 787
TIM3 comes of age as an inhibitory receptor
Yochai Wolf, Ana C. Anderson, Vijay K. Kuchroo
Nature reviews. Immunology (2019) Vol. 20, Iss. 3, pp. 173-185
Open Access | Times Cited: 743
Advances in the development of personalized neoantigen-based therapeutic cancer vaccines
Eryn Blass, Patrick A. Ott
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 4, pp. 215-229
Open Access | Times Cited: 738
Developmental Relationships of Four Exhausted CD8+ T Cell Subsets Reveals Underlying Transcriptional and Epigenetic Landscape Control Mechanisms
Jean‐Christophe Beltra, Sasikanth Manne, Mohamed S. Abdel-Hakeem, et al.
Immunity (2020) Vol. 52, Iss. 5, pp. 825-841.e8
Open Access | Times Cited: 716
CD8+ T cell differentiation and dysfunction in cancer
Mary Philip, Andrea Schietinger
Nature reviews. Immunology (2021) Vol. 22, Iss. 4, pp. 209-223
Open Access | Times Cited: 666
An intra-tumoral niche maintains and differentiates stem-like CD8 T cells
Caroline S. Jansen, Nataliya Prokhnevska, Viraj A. Master, et al.
Nature (2019) Vol. 576, Iss. 7787, pp. 465-470
Open Access | Times Cited: 650
Tertiary lymphoid structures in cancer
Ton N. Schumacher, Daniela S. Thommen
Science (2022) Vol. 375, Iss. 6576
Closed Access | Times Cited: 635
Tumor-infiltrating lymphocytes in the immunotherapy era
Sterre T. Paijens, Annegé Vledder, Marco de Bruyn, et al.
Cellular and Molecular Immunology (2020) Vol. 18, Iss. 4, pp. 842-859
Open Access | Times Cited: 633
Intratumoral heterogeneity in cancer progression and response to immunotherapy
Ilio Vitale, Efrat Shema, Sherene Loi, et al.
Nature Medicine (2021) Vol. 27, Iss. 2, pp. 212-224
Closed Access | Times Cited: 561
Intratumoral Activity of the CXCR3 Chemokine System Is Required for the Efficacy of Anti-PD-1 Therapy
Melvyn T. Chow, Aleksandra J. Ozga, Rachel L. Servis, et al.
Immunity (2019) Vol. 50, Iss. 6, pp. 1498-1512.e5
Open Access | Times Cited: 542
CD4+ T Cell Help Is Required for the Formation of a Cytolytic CD8+ T Cell Subset that Protects against Chronic Infection and Cancer
Ryan Zander, David Schauder, Gang Xin, et al.
Immunity (2019) Vol. 51, Iss. 6, pp. 1028-1042.e4
Open Access | Times Cited: 516
Chemokines and the immune response to cancer
Aleksandra J. Ozga, Melvyn T. Chow, Andrew D. Luster
Immunity (2021) Vol. 54, Iss. 5, pp. 859-874
Open Access | Times Cited: 492
Clinical implications of T cell exhaustion for cancer immunotherapy
Andrew Chow, Karlo Perica, Christopher A. Klebanoff, et al.
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 12, pp. 775-790
Open Access | Times Cited: 492
The PD-1/PD-L1-Checkpoint Restrains T cell Immunity in Tumor-Draining Lymph Nodes
Floris Dammeijer, Mandy van Gulijk, Evalyn E.A.P. Mulder, et al.
Cancer Cell (2020) Vol. 38, Iss. 5, pp. 685-700.e8
Open Access | Times Cited: 467
The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies
Florent Petitprez, Maxime Meylan, Aurélien de Reyniès, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 464
Single-cell RNA-seq reveals TOX as a key regulator of CD8+ T cell persistence in chronic infection
Chen Yao, Hong‐Wei Sun, Neal E. Lacey, et al.
Nature Immunology (2019) Vol. 20, Iss. 7, pp. 890-901
Open Access | Times Cited: 463
Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8+ T cells in tumors
Shihao Xu, Omkar Chaudhary, Patricia Rodríguez-Morales, et al.
Immunity (2021) Vol. 54, Iss. 7, pp. 1561-1577.e7
Open Access | Times Cited: 460
Targeting the epigenetic regulation of antitumour immunity
Simon J. Hogg, Paul A. Beavis, Mark A. Dawson, et al.
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 11, pp. 776-800
Closed Access | Times Cited: 449
T cell stemness and dysfunction in tumors are triggered by a common mechanism
Suman K. Vodnala, Robert Eil, Rigel J. Kishton, et al.
Science (2019) Vol. 363, Iss. 6434
Open Access | Times Cited: 440
VEGF-C-driven lymphatic drainage enables immunosurveillance of brain tumours
Eric Song, Tianyang Mao, Huiping Dong, et al.
Nature (2020) Vol. 577, Iss. 7792, pp. 689-694
Open Access | Times Cited: 417
Page 1 - Next Page

Scroll to top